Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?

Current approaches to testing new treatments for multidrug resistant bacterial diseases raise scientific and ethical issues for current and future patients, say John Powers and colleagues

Primary Author

Powers,John H.

Evans,Scott R.

Kesselheim,Aaron S.

Volume

360

Other Pages

k587

Publisher

BMJ Publishing Group LTD

URL

http://dx.doi.org/10.1136/bmj.k587

PMID

29472192

Reference Type

Journal Article

Periodical Full

BMJ

Publication Year

2018

Publication Date

February 22,

Place of Publication

England

ISSN/ISBN

0959-8138

Document Object Index

10.1136/bmj.k587